111614
论文已发表
注册即可获取德孚的最新动态
IF 收录期刊
- 3.4 Breast Cancer (Dove Med Press)
- 3.2 Clin Epidemiol
- 2.6 Cancer Manag Res
- 2.9 Infect Drug Resist
- 3.7 Clin Interv Aging
- 5.1 Drug Des Dev Ther
- 3.1 Int J Chronic Obstr
- 6.6 Int J Nanomed
- 2.6 Int J Women's Health
- 2.9 Neuropsych Dis Treat
- 2.8 OncoTargets Ther
- 2.0 Patient Prefer Adher
- 2.2 Ther Clin Risk Manag
- 2.5 J Pain Res
- 3.0 Diabet Metab Synd Ob
- 3.2 Psychol Res Behav Ma
- 3.4 Nat Sci Sleep
- 1.8 Pharmgenomics Pers Med
- 2.0 Risk Manag Healthc Policy
- 4.1 J Inflamm Res
- 2.0 Int J Gen Med
- 3.4 J Hepatocell Carcinoma
- 3.0 J Asthma Allergy
- 2.2 Clin Cosmet Investig Dermatol
- 2.4 J Multidiscip Healthc
已发表论文
CD38+细胞水平与糖尿病合并肺结核的相关性：基于淋巴细胞亚群及临床特征的回顾性分析
Authors Wang Y , Mao W, Xu L, Xu W
Received 30 July 2025
Accepted for publication 24 November 2025
Published 6 December 2025 Volume 2025:18 Pages 4483—4491
DOI https://doi.org/10.2147/DMSO.S556747
Checked for plagiarism Yes
Review by Single anonymous peer review
Peer reviewer comments 2
Editor who approved publication: Dr Hillary Keenan
Yanan Wang, Weifang Mao, Lin Xu, Wenfang Xu
Clinical Laboratory, Affiliated Hospital of Shaoxing University, Shaoxing, Zhejiang, People’s Republic of China
Correspondence: Wenfang Xu, Affiliated Hospital of Shaoxing University, No. 999 Zhongxing South Road, Yuecheng District, Shaoxing, Zhejiang, People’s Republic of China, Email xwf1101@126.com
Purpose: This study aimed to investigate the association between CD38+ cells and the risk of pulmonary tuberculosis (PTB) complicated with diabetes mellitus (DM), providing insights into the immune mechanisms underlying PTB-DM.
Patients and Methods: Clinical data and lymphocyte subset profiles of 596 TB patients admitted to Affiliated Hospital of Shaoxing University from November 2022 to November 2024 were analyzed, including 115 DM-complicated and 481 non-DM cases. Logistic regression was used to evaluate the correlations between clinical indicators, lymphocyte subsets and PTB-DM. Generalized linear models were employed to assess the association of CD38+ cells with PTB-DM risk, while restricted cubic spline curves were used to explore potential linear relationships.
Results: The PTB-DM group exhibited a significantly higher prevalence of advanced age, male gender, and hypertension compared to the non-DM group (p < 0.05). Lymphocyte subset analysis revealed marginally elevated NKT cells but reduced B lymphocytes, B1 cells, and CD38+ cells in the DM group, with the most pronounced difference in CD38+ cells (p < 0.001). Multivariate logistic regression identified multidrug-resistant TB and hypertension as independent risk factors, whereas higher CD38+ cell counts served as an independent protective factor for TB-DM comorbidity (OR 0.50, 95% CI 0.32– 0.77). Generalized linear models demonstrated a persistent negative correlation between CD38+ cell levels (analyzed as continuous or quartile-categorized variables) and PTB-DM risk after adjusting for confounders. Restricted cubic spline analysis confirmed a significant linear inverse association (p = 0.003) without evidence of nonlinearity (p = 0.450).
Conclusion: CD38+ cells play a critical role in the immune regulation of PTB patients, with elevated expression conferring protective effects against PTB-DM comorbidity.
Keywords: CD38+ cells, tuberculosis, diabetes mellitus, immune regulation
Clinical Laboratory, Affiliated Hospital of Shaoxing University, Shaoxing, Zhejiang, People’s Republic of China
Correspondence: Wenfang Xu, Affiliated Hospital of Shaoxing University, No. 999 Zhongxing South Road, Yuecheng District, Shaoxing, Zhejiang, People’s Republic of China, Email xwf1101@126.com
Purpose: This study aimed to investigate the association between CD38+ cells and the risk of pulmonary tuberculosis (PTB) complicated with diabetes mellitus (DM), providing insights into the immune mechanisms underlying PTB-DM.
Patients and Methods: Clinical data and lymphocyte subset profiles of 596 TB patients admitted to Affiliated Hospital of Shaoxing University from November 2022 to November 2024 were analyzed, including 115 DM-complicated and 481 non-DM cases. Logistic regression was used to evaluate the correlations between clinical indicators, lymphocyte subsets and PTB-DM. Generalized linear models were employed to assess the association of CD38+ cells with PTB-DM risk, while restricted cubic spline curves were used to explore potential linear relationships.
Results: The PTB-DM group exhibited a significantly higher prevalence of advanced age, male gender, and hypertension compared to the non-DM group (p < 0.05). Lymphocyte subset analysis revealed marginally elevated NKT cells but reduced B lymphocytes, B1 cells, and CD38+ cells in the DM group, with the most pronounced difference in CD38+ cells (p < 0.001). Multivariate logistic regression identified multidrug-resistant TB and hypertension as independent risk factors, whereas higher CD38+ cell counts served as an independent protective factor for TB-DM comorbidity (OR 0.50, 95% CI 0.32– 0.77). Generalized linear models demonstrated a persistent negative correlation between CD38+ cell levels (analyzed as continuous or quartile-categorized variables) and PTB-DM risk after adjusting for confounders. Restricted cubic spline analysis confirmed a significant linear inverse association (p = 0.003) without evidence of nonlinearity (p = 0.450).
Conclusion: CD38+ cells play a critical role in the immune regulation of PTB patients, with elevated expression conferring protective effects against PTB-DM comorbidity.
Keywords: CD38+ cells, tuberculosis, diabetes mellitus, immune regulation